Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives, Dan Lynch, and ...

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus ...

The American pharmaceutical company Bristol Myers Squibb, together with the venture capital firm Bain Capital, is forming a ...